Skip to main
DFTX

DFTX Earnings Dates & Reports

DFTX Most Recent Earnings

Report Date
Period EndingQ3 2025
Est. EPS-$0.51
Actual EPS-$0.78
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

DFTX Earnings per Share (EPS) History

Signup for full access
Browse free

DFTX Latest Earnings

The value each DFTX share was expected to gain vs. the value each share gained.

DFTX reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of -$0.78. This exceeded analysts' expectations of -$0.51 by 52.94%, marking a Miss.

For comparison, Definium Therapeutics Inc reported EPS of -$0.27 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.49.

DFTX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025
-$0.49
Q3 2025
-$0.51-$0.78+52.94%
DeckReportListen
Q2 2025
-$0.37-$0.50+35.14%
DeckReportListen
Q1 2025
-$0.37-$0.35-5.41%
DeckReportListen
Q4 2024
-$0.28-$0.41+46.43%
DeckReportListen
View all

DFTX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Definium Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

DFTX Earnings FAQs

DFTX last reported earnings on Nov 6, 2025 for Q3 2025, posting an EPS of -$0.78, which Miss the estimate of -$0.51 by 52.94%.

For Q3 2025, DFTX reported an EPS of -$0.78, missing analysts' estimate of -$0.51 by 52.94%.

For Q3 2025, DFTX Miss expectations with an actual EPS of -$0.78 vs. an estimated EPS of -$0.51.

Following the last earnings report on Nov 6, 2025, DFTX's stock price moved — from — to —.

The next DFTX earnings call is scheduled for Mar. 5, 2026, where executives will discuss financial results and outlook.

Definium Therapeutics Inc (DFTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.